Elevance Health (ELV) came out with quarterly earnings of $10.12 per share, beating the Zacks Consensus Estimate of $9.99 per share. This compares to earnings of $9.04 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 1.30%. A quarter ago, it was expected that this health insurer would post earnings of $10.54 per share when it actually produced earnings of $10.64, delivering a surprise of 0.95%. Over the last four quarters, the ...

Key Highlights • 2Q 2024 adjusted diluted EPS of $10.12 grew 12% year-over-year 2024 Outlook 2 • Guidance embeds investment in strategic growth initiatives, notably in CarelonRx, as we integrate recent acquisitions and scale key value drivers Strategic Focus Areas 3 • Building a sustainable Medicare Advantage business for the long-term 2 • Operating revenue was impacted by declines in Medicaid membership, partially offset by premium rate increases to cover medical cost trends 1. See "Basis of Presentation" ...

Elevance Health, Inc. (ELV) is scheduled to report second-quarter 2024 results on Jul 17, before the opening bell. The Zacks Consensus Estimate for second-quarter earnings per share of $10 indicates a 10.6% increase from the prior-year figure of $9.04. The estimate increased by a penny in the past week. However, the consensus estimate for second-quarter revenues of $43 billion indicates a 0.9% decline from the year-ago reported figure. Elevance Health beat the consensus estimate for earnings in all the prio ...

In its upcoming report, Elevance Health (ELV) is predicted by Wall Street analysts to post quarterly earnings of $10 per share, reflecting an increase of 10.6% compared to the same period last year. Revenues are forecasted to be $42.99 billion, representing a year-over-year decrease of 0.9%. Over the last 30 days, there has been an upward revision of 0.3% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their ini ...

Notably, the Health Care Select Sector SPDR Fund (NYSEARCA:XLV), the largest healthcare exchangetraded fund ("ETF"), has gained 7% year to date ("YTD"). This return demonstrates a clear appetite for exposure to the promising landscape of U.S. healthcare stocks. Meanwhile, within this dynamic sector, certain companies stand out. These "healthy" healthcare stocks exhibit robust fundamentals, innovative approaches, and a clear vision for future success. Therefore, today, we explore three of the healthiest heal ...

Elevance Health, with a market capitalization of $122.6 billion, is one of the largest publicly traded health benefits providers in the United States. The company also boasts a prudent capital deployment history. These factors are collectively contributing to this Zacks Rank #2 (Buy) company's notable price appreciation. Image Source: Zacks Investment Research The consensus mark for full-year 2024 revenues stands at nearly $172.1 billion, suggesting a 1.1% rise from the prior-year reported number. Our estim ...

Source: Shutterstock.com Humana (NYSE:HUM) is the second-largest Medicare Advantage firm with 18% market share from 5.5 million enrolled. It has the largest Medicare Advantage market share in nine states including Florida at 31%. In late April, Humana reported Q1 2024 results that included raising its Medicare Advantage growth in 2024 by 50,000, to 150,000, 2.8% higher than in 2023. In Q1 2024, its revenue from individual and group Medicare Advantage customer premiums was $24.44 billion, up 13.3% from $21.5 ...

Elevance Health (ELV) shares ended the last trading session 6.1% higher at $538.48. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 3.5% loss over the past four weeks. Elevance Health extended its rally for the second straight day, driven by continued optimism over its Health Benefits and Carelon businesses. Baird analyst Michael Ha also initiated coverage of the stock with an Outperform rating, which further drove ...

Shares of Elevance Health, Inc. (ELV) have jumped 14.9% in the year-to-date period compared with the 4.8% growth of the industry it belongs to, thanks to its strong operations, new contracts in its Government business and optimization efforts. Factors such as premium rate increases and inorganic growth initiatives are further enhancing its results, allowing the company to raise its guidance, which has been well-received by investors. Elevance Health, with a market capitalization of $127.3 billion, is one of ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both. Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor. Zacks Premium also includes the Zacks Style Scores. What ar ...